Characterization of Human Colorectal Cancer MDR1/P-gp Fab Antibody

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="1"><hr/></td></tr><tr><td align="left"><img alt="716289.tab.001a" src="https://static.hindawi.com/articles/tswj/volume-2013/716289/figures/716289.tab.001a.jpg"/></td></tr><tr><td align="left" colspan="1"><hr/></td></tr><tr><td align="left"><img alt="716289.tab.001b" src="https://static.hindawi.com/articles/tswj/volume-2013/716289/figures/716289.tab.001b.jpg"/></td></tr><tr class="table-tr"><td colspan="1"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td>The sequences with underlines are three epitopes analyzed by BepiPred 1.0b Server; the nucleotides located as number 442 and number 484 (italics) were different from the retrieval sequences and their translated amino acid changed from serine to alanine as a result. The alanine located as number 148 and number 162 has no effect on the antigenicity of the three epitopes.<br/></td></tr></table>

BLAST of the P-gp<sub>21</sub> sequence with that retrieved from NCBI.

The Scientific World Journal

tab1

Table 1

Table 1: Characterization of Human Colorectal Cancer MDR1/P-gp Fab Antibody 